ArticleCancer gene therapy2015

Lenalidomide enhances the function of chimeric antigen receptor T cells against the epidermal growth factor receptor variant III by enhancing immune synapses.

S Kuramitsu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.